Literature DB >> 15219499

Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial).

Satish Kenchaiah1, Marc A Pfeffer, Martin St John Sutton, Ted Plappert, Jean-Lucien Rouleau, Gervasio A Lamas, Zion Sasson, John O Parker, Edward M Geltman, Scott D Solomon.   

Abstract

Whether antecedent systemic hypertension influences the risk of subsequent left ventricular (LV) dilation in patients after an acute myocardial infarction with LV systolic dysfunction is unclear. We assessed echocardiographic evidence of ventricular remodeling from baseline (mean +/- SD 11 +/- 3 days) to 2 years after an acute myocardial infarction in 122 hypertensive (defined as a history of treated hypertension, baseline systolic blood pressure > or =140 or baseline diastolic blood pressure > or =90 mm Hg) and 334 nonhypertensive patients in the Survival and Ventricular Enlargement echocardiographic substudy. Compared with nonhypertensives, baseline heart size, defined as the sum of the average short- and long-axis LV cavity areas, was similar (70.1 +/- 11.9 vs 68.8 +/- 11.2 cm(2), p = 0.33 at end-diastole; 50.1 +/- 11.3 vs 48.8 +/- 10.8 cm(2), p = 0.31 at end-systole), but short-axis LV myocardial area (24.7 +/- 4.3 vs 25.7 +/- 5.0 cm(2), p = 0.043) and wall thickness (1.15 +/- 0.16 vs 1.21 +/- 0.17 cm, p = 0.004) at end-diastole were greater among hypertensives. The myocardial infarct segment lengths were similar in the 2 groups (p = 0.22). Although LV cavity areas increased significantly in the 2 groups from baseline to 2 years (p < or =0.001), the increase was significantly greater in hypertensives than in nonhypertensives (+5.6 +/- 11.5 vs +2.2 +/- 10.7 cm(2), p = 0.005 at end-diastole; +6.23 +/- 12.75 vs +2.94 +/- 11.4 cm(2), p = 0.012 at end-systole). There was no concomitant difference in the change in LV myocardial area or LV wall thickness between the 2 groups (p >0.30). After adjusting for known confounders, antecedent hypertension was associated with a doubling of the risk of LV dilation (50.8% vs 37.7%, odds ratio 2.09, 95% confidence interval 1.27 to 3.45, p = 0.004). This association was not modified by diabetes mellitus, myocardial infarct segment length, or captopril use (all p values for interaction >0.10). We conclude that antecedent hypertension is associated with subsequent LV dilation in patients after acute myocardial infarction with LV systolic dysfunction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219499     DOI: 10.1016/j.amjcard.2004.03.020

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  13 in total

1.  Novel mouse model of left ventricular pressure overload and infarction causing predictable ventricular remodelling and progression to heart failure.

Authors:  Carla J Weinheimer; Ling Lai; Daniel P Kelly; Attila Kovacs
Journal:  Clin Exp Pharmacol Physiol       Date:  2015-01       Impact factor: 2.557

2.  Acute Cardiac Unloading and Recovery: Proceedings of the 4th Annual Acute Cardiac Unloading and REcovery (A-CURE) symposium held on 30 August 2019 in Paris, France.

Authors: 
Journal:  Interv Cardiol       Date:  2019-11-18

Review 3.  Left ventricular diastolic function following myocardial infarction.

Authors:  Jens Jakob Thune; Scott D Solomon
Journal:  Curr Heart Fail Rep       Date:  2006-12

4.  Role of the complement components C5 and C3a in a mouse model of myocardial ischemia and reperfusion injury.

Authors:  Marc N Busche; Gregory L Stahl
Journal:  Ger Med Sci       Date:  2010-09-08

5.  A history of systemic hypertension and incident heart failure hospitalization in patients with acute myocardial infarction and left ventricular systolic dysfunction.

Authors:  Ali Ahmed; Bertram Pitt
Journal:  Am J Cardiol       Date:  2009-04-01       Impact factor: 2.778

6.  Mannose-binding lectin plays a critical role in myocardial ischaemia and reperfusion injury in a mouse model of diabetes.

Authors:  M N Busche; M C Walsh; M E McMullen; B J Guikema; G L Stahl
Journal:  Diabetologia       Date:  2008-05-21       Impact factor: 10.122

7.  Humanized cobra venom factor decreases myocardial ischemia-reperfusion injury.

Authors:  W Brian Gorsuch; Benjamin J Guikema; David C Fritzinger; Carl-Wilhelm Vogel; Gregory L Stahl
Journal:  Mol Immunol       Date:  2009-09-10       Impact factor: 4.407

8.  Myocardial ischemia and reperfusion injury is dependent on both IgM and mannose-binding lectin.

Authors:  Marc N Busche; Vasile Pavlov; Kazue Takahashi; Gregory L Stahl
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-11       Impact factor: 4.733

9.  History of hypertension and eplerenone in patients with acute myocardial infarction complicated by heart failure.

Authors:  Bertram Pitt; Ali Ahmed; Thomas E Love; Henry Krum; Jose Nicolau; José S Cardoso; Alexander Parkhomenko; Michael Aschermann; Ramon Corbalán; Henry Solomon; Harry Shi; Faiez Zannad
Journal:  Hypertension       Date:  2008-06-16       Impact factor: 10.190

10.  Load-Dependent Changes in Left Ventricular Structure and Function in a Pathophysiologically Relevant Murine Model of Reversible Heart Failure.

Authors:  Carla J Weinheimer; Attila Kovacs; Sarah Evans; Scot J Matkovich; Philip M Barger; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2018-05       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.